Raul Moreno REFERENCE: Abstract 3103, European Society of Cardiology Congress, 2007, 1-5 September, Vienna, Austria RAUL MORENO, University Hospital La Paz, Madrid Results from a large meta analysis s
Raul Moreno
REFERENCE: Abstract 3103, European Society of Cardiology Congress, 2007, 1-5 September, Vienna, AustriaRAUL MORENO, University Hospital La Paz, MadridResults from a large meta analysis suggest that drug eluting stents have a greater benefit when the risk of restenosis increases. This could affect the “off label” use of these stents.Raul Moreno, of the University Hospital La Paz, Madrid, discussed his findings with Derek Thorne.
Related Episodes
TAXUS DES Trials Results: How Long Should Thienopyridine Be Used After Drug Eluting Stent?
Gregg Stone REFERENCE: Abstract 2357, American Heart Association Scientific Sessions, 4-7 November, 2007, Orlando, Florida GREGG STONE, Columbia University, New York New light has been thrown on the u
Long Term Outcomes of Drug Eluting and Bare Metal Stents in Patients Undergoing PCI
Laura Mauri Raymond Gibbons REFERENCE: Late Breaking Special Session, American Heart Association Scientific Sessions, 4-7 November, 2007, Orlando, Florida LAURA MAURI, Brigham and Woman’s Hospit
Drug Eluting Stent Shows Great Benefit in Chronic Total Occlusions
Gerald Werner REFERENCE: Abstract 925, European Society of Cardiology Congress, 2007, 1-5 September, Vienna, Austria GERALD WERNER, Klinikum Darmstadt, Germany The ESC congress in Vienna heard that dr